The formation of an antibacterial agent-apatite composite coating on a polymer surface using a metastable calcium phosphate solution.

[1]  A. Oyane,et al.  Biological Evaluation of a Laminin–Apatite–Polymer Composite for Use in Skin Terminals , 2006 .

[2]  B. N. Bachra,et al.  The effect of tetracycline and oxytetracycline on the formation of biological apatite , 1973, Calcified Tissue Research.

[3]  K. Onuma,et al.  Spontaneous growth of a laminin-apatite nano-composite in a metastable calcium phosphate solution. , 2006, Biomaterials.

[4]  C. Choong,et al.  Simple surface modification of poly(ε-caprolactone) for apatite deposition from simulated body fluid , 2005 .

[5]  A. Oyane,et al.  Laminin-apatite composite coating to enhance cell adhesion to ethylene-vinyl alcohol copolymer. , 2005, Journal of biomedical materials research. Part A.

[6]  A. Oyane,et al.  Ultra-Structural Study of the Laminin-Apatite Composite Layer Formed on Ethylene-Vinyl Alcohol Copolymer by a Biomimetic Process , 2005 .

[7]  P. Layrolle,et al.  Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[8]  A. Oyane,et al.  Biomimetic Coating of Laminin–Apatite Composite on Titanium Metal and Its Excellent Cell‐Adhesive Properties , 2004 .

[9]  M. Tomita,et al.  Lactoferricin derived from milk protein lactoferrin. , 2003, Current pharmaceutical design.

[10]  J. Tanaka,et al.  Physical and biological evaluations of sintered hydroxyapatite/silicone composite with covalent bonding for a percutaneous implant material. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[11]  P. Layrolle,et al.  Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. , 2002, Biomaterials.

[12]  T. Yamamoto,et al.  In vitro method for prediction of the phototoxic potentials of fluoroquinolones. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  J. Tanaka,et al.  A hydroxyapatite coating covalently linked onto a silicone implant material. , 2001, Journal of biomedical materials research.

[14]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[15]  P. Appelbaum,et al.  The fluoroquinolone antibacterials: past, present and future perspectives. , 2000, International journal of antimicrobial agents.

[16]  K. Yamauchi,et al.  13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  J. Blondeau,et al.  Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. , 2000, International journal of antimicrobial agents.

[18]  T. Yasue,et al.  Inhibitory Activities of Gatifloxacin (AM-1155), a Newly Developed Fluoroquinolone, against Bacterial and Mammalian Type II Topoisomerases , 1998, Antimicrobial Agents and Chemotherapy.

[19]  Shin,et al.  Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7 , 1998, Letters in applied microbiology.

[20]  I. Witte,et al.  Enhanced cyto- and genotoxicity of tetracycline in Wilson disease fibroblasts. , 1995, Mutation research.

[21]  D. Chrisey,et al.  Pulsed laser deposition of thin film hydroxyapatite. Applications for flexible catheters. , 1994, ASAIO journal.

[22]  J. Elliott,et al.  Structure and chemistry of the apatites and other calcium orthophosphates , 1994 .

[23]  H. Aoyama,et al.  In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone , 1992, Antimicrobial Agents and Chemotherapy.

[24]  H. Aoki,et al.  Surface properties of hydroxyapatite ceramic as new percutaneous material in skin tissue , 1992 .

[25]  H. Kozłowski,et al.  Metal ion-tetracycline interactions in biological fluids. 9. Circular dichroism spectra of calcium and magnesium complexes with tetracycline, oxytetracycline, doxycycline, and chlortetracycline and discussion of their binding modes , 1988 .

[26]  M. Brion,et al.  Metal iontetracyclines interactions in biological fluids. Potentiometric study of calcium complexes with tetracycline, oxytetracycline, doxycycline and minocycline and simulation of their distributions under physiological conditions , 1981 .

[27]  H. Rogers,et al.  Iron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants , 1972, Proceedings of the Royal Society of Medicine.

[28]  I. Nakayama,et al.  [Minocycline in the surgical field]. , 1969, The Japanese journal of antibiotics.

[29]  L. Mitscher,et al.  Interaction of various tetracyclines with metallic cations in aqueous solutions as measured by by circular dichroism. , 1969, Antimicrobial agents and chemotherapy.